Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 22 | 2024 | 3843 | 1.410 |
Why?
|
| Hydrocephalus | 3 | 2024 | 277 | 0.960 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2024 | 50 | 0.920 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 37 | 0.760 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 357 | 0.660 |
Why?
|
| Pons | 2 | 2024 | 34 | 0.570 |
Why?
|
| Leukoencephalopathies | 2 | 2018 | 61 | 0.550 |
Why?
|
| Contrast Media | 6 | 2022 | 507 | 0.510 |
Why?
|
| Societies, Medical | 6 | 2022 | 778 | 0.470 |
Why?
|
| Neck Injuries | 1 | 2014 | 25 | 0.420 |
Why?
|
| Angiography | 1 | 2014 | 208 | 0.410 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 82 | 0.410 |
Why?
|
| Child | 29 | 2024 | 25765 | 0.400 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 602 | 0.390 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2015 | 373 | 0.380 |
Why?
|
| White Matter | 1 | 2015 | 212 | 0.380 |
Why?
|
| Brain Stem | 2 | 2022 | 119 | 0.380 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 221 | 0.370 |
Why?
|
| Vestibular Nerve | 1 | 2011 | 8 | 0.360 |
Why?
|
| Neuroimaging | 7 | 2023 | 376 | 0.350 |
Why?
|
| Brain | 5 | 2023 | 3182 | 0.340 |
Why?
|
| Nervous System Malformations | 1 | 2011 | 131 | 0.320 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 156 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2022 | 2164 | 0.300 |
Why?
|
| Diagnosis, Differential | 9 | 2025 | 1957 | 0.290 |
Why?
|
| Craniocerebral Trauma | 2 | 2020 | 140 | 0.290 |
Why?
|
| Evidence-Based Medicine | 6 | 2022 | 662 | 0.290 |
Why?
|
| Sinusitis | 2 | 2020 | 119 | 0.280 |
Why?
|
| Humans | 45 | 2025 | 132013 | 0.280 |
Why?
|
| Epilepsy | 1 | 2015 | 889 | 0.280 |
Why?
|
| Inflammation | 1 | 2015 | 1519 | 0.260 |
Why?
|
| Pediatrics | 1 | 2015 | 1211 | 0.240 |
Why?
|
| Retrospective Studies | 14 | 2024 | 17374 | 0.240 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 1173 | 0.240 |
Why?
|
| Infant | 12 | 2024 | 13050 | 0.240 |
Why?
|
| Demyelinating Diseases | 2 | 2018 | 70 | 0.240 |
Why?
|
| Seizures | 3 | 2025 | 892 | 0.220 |
Why?
|
| Cranial Nerves | 1 | 2024 | 19 | 0.220 |
Why?
|
| Brain Neoplasms | 3 | 2022 | 1404 | 0.220 |
Why?
|
| Skull | 2 | 2022 | 143 | 0.220 |
Why?
|
| Skull Base | 1 | 2024 | 51 | 0.210 |
Why?
|
| Tuberculosis, Spinal | 1 | 2023 | 9 | 0.210 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2023 | 11 | 0.210 |
Why?
|
| Actinomycetaceae | 1 | 2023 | 6 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2003 | 8 | 0.210 |
Why?
|
| Actinomycosis | 1 | 2023 | 8 | 0.210 |
Why?
|
| Hysterotomy | 1 | 2024 | 127 | 0.210 |
Why?
|
| Empyema | 1 | 2023 | 24 | 0.210 |
Why?
|
| Laparotomy | 1 | 2024 | 144 | 0.210 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2003 | 21 | 0.210 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 28 | 0.200 |
Why?
|
| Child, Preschool | 13 | 2025 | 14736 | 0.200 |
Why?
|
| Globus Pallidus | 1 | 2003 | 69 | 0.200 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 313 | 0.200 |
Why?
|
| Basal Ganglia | 1 | 2003 | 63 | 0.200 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 1859 | 0.200 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 53 | 0.200 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2023 | 74 | 0.190 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2023 | 35 | 0.190 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 10 | 0.190 |
Why?
|
| Survivorship | 1 | 2022 | 44 | 0.180 |
Why?
|
| Tinnitus | 1 | 2022 | 23 | 0.180 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 69 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 253 | 0.180 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 34 | 0.180 |
Why?
|
| Anemia | 1 | 2025 | 350 | 0.180 |
Why?
|
| Scalp | 1 | 2021 | 57 | 0.180 |
Why?
|
| Female | 20 | 2024 | 70643 | 0.180 |
Why?
|
| Meningomyelocele | 1 | 2024 | 253 | 0.180 |
Why?
|
| Prognosis | 3 | 2024 | 5008 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2022 | 244 | 0.170 |
Why?
|
| Proton Therapy | 1 | 2022 | 159 | 0.170 |
Why?
|
| Malignant Atrophic Papulosis | 1 | 2020 | 3 | 0.170 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 19 | 0.170 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.160 |
Why?
|
| Fetoscopy | 1 | 2024 | 448 | 0.160 |
Why?
|
| Mitochondrial Diseases | 1 | 2022 | 147 | 0.160 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 248 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 270 | 0.160 |
Why?
|
| Hematoma, Subdural | 1 | 2019 | 25 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 54 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 118 | 0.150 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8542 | 0.150 |
Why?
|
| Male | 19 | 2024 | 64914 | 0.150 |
Why?
|
| Spinal Injuries | 1 | 2019 | 33 | 0.150 |
Why?
|
| Meningitis, Viral | 1 | 2018 | 10 | 0.150 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2018 | 11 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2023 | 154 | 0.150 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2018 | 12 | 0.150 |
Why?
|
| Temporal Bone | 2 | 2018 | 36 | 0.150 |
Why?
|
| Myelitis | 1 | 2018 | 15 | 0.150 |
Why?
|
| Cochlea | 1 | 2018 | 88 | 0.140 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 50 | 0.140 |
Why?
|
| Brain Injuries | 1 | 2003 | 716 | 0.140 |
Why?
|
| Polyneuropathies | 1 | 2018 | 31 | 0.140 |
Why?
|
| Ipilimumab | 1 | 2018 | 60 | 0.140 |
Why?
|
| West Nile virus | 1 | 2018 | 117 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 299 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 372 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 139 | 0.130 |
Why?
|
| Child Abuse | 1 | 2019 | 204 | 0.130 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 125 | 0.130 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2016 | 12 | 0.120 |
Why?
|
| Pregnancy | 3 | 2024 | 7554 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 411 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 654 | 0.120 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2014 | 8 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 380 | 0.110 |
Why?
|
| Transverse Sinuses | 1 | 2014 | 1 | 0.110 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 391 | 0.110 |
Why?
|
| Hearing Aids | 1 | 2014 | 32 | 0.110 |
Why?
|
| Vertebral Artery | 1 | 2014 | 22 | 0.110 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 83 | 0.100 |
Why?
|
| Glasgow Coma Scale | 1 | 2014 | 200 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 7 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 111 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 631 | 0.100 |
Why?
|
| Neck | 1 | 2014 | 142 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2013 | 48 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 85 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1183 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 165 | 0.100 |
Why?
|
| Adolescent | 7 | 2024 | 20544 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 376 | 0.090 |
Why?
|
| Audiometry | 1 | 2011 | 23 | 0.090 |
Why?
|
| Sampling Studies | 1 | 2011 | 77 | 0.090 |
Why?
|
| Ataxia | 2 | 2022 | 177 | 0.080 |
Why?
|
| Cochlear Implantation | 1 | 2011 | 53 | 0.080 |
Why?
|
| Melanoma | 1 | 2018 | 952 | 0.080 |
Why?
|
| Survivors | 2 | 2022 | 354 | 0.080 |
Why?
|
| Risk Factors | 2 | 2015 | 10931 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2011 | 209 | 0.070 |
Why?
|
| Organometallic Compounds | 2 | 2013 | 111 | 0.070 |
Why?
|
| Cytokines | 1 | 2015 | 1365 | 0.070 |
Why?
|
| Syndrome | 1 | 2011 | 1174 | 0.070 |
Why?
|
| United States | 5 | 2021 | 11655 | 0.070 |
Why?
|
| Electroencephalography | 1 | 2011 | 907 | 0.060 |
Why?
|
| Biomarkers | 1 | 2015 | 3402 | 0.060 |
Why?
|
| Meninges | 1 | 2023 | 22 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2015 | 6568 | 0.050 |
Why?
|
| Heterocyclic Compounds | 1 | 2003 | 18 | 0.050 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2003 | 4 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2003 | 49 | 0.050 |
Why?
|
| Joint Diseases | 1 | 2003 | 34 | 0.050 |
Why?
|
| Spin Labels | 1 | 2023 | 21 | 0.050 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 29 | 0.050 |
Why?
|
| Streptococcus gallolyticus | 1 | 2022 | 3 | 0.050 |
Why?
|
| Gadolinium | 1 | 2003 | 116 | 0.050 |
Why?
|
| Streptococcus | 1 | 2022 | 63 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2022 | 71 | 0.050 |
Why?
|
| Protons | 1 | 2022 | 98 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2022 | 63 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 149 | 0.050 |
Why?
|
| Encephalitis | 1 | 2023 | 118 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2023 | 273 | 0.050 |
Why?
|
| Penicillins | 1 | 2022 | 155 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2020 | 36 | 0.040 |
Why?
|
| Gestational Age | 1 | 2024 | 1226 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 61 | 0.040 |
Why?
|
| Biological Factors | 1 | 2020 | 27 | 0.040 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 28 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 52 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 46 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2003 | 383 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2020 | 78 | 0.040 |
Why?
|
| Nitriles | 1 | 2020 | 154 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 438 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 110 | 0.040 |
Why?
|
| Workplace | 1 | 2020 | 82 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 373 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 990 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 2139 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 57 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 94 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 462 | 0.040 |
Why?
|
| Cerebral Aqueduct | 1 | 2018 | 11 | 0.040 |
Why?
|
| Adult | 4 | 2023 | 31563 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2020 | 283 | 0.040 |
Why?
|
| Family | 1 | 2021 | 595 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 332 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 673 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1168 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 257 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 527 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 418 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 810 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1177 | 0.030 |
Why?
|
| Mitochondria | 1 | 2022 | 749 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 550 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 216 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5409 | 0.030 |
Why?
|
| Suture Anchors | 1 | 2014 | 3 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12987 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 589 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 243 | 0.030 |
Why?
|
| Texas | 1 | 2022 | 3627 | 0.030 |
Why?
|
| Optic Disk | 1 | 2014 | 49 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2226 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 304 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 235 | 0.030 |
Why?
|
| Meglumine | 1 | 2013 | 16 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 2013 | 35 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2014 | 114 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 431 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 665 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5166 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2655 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3008 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2311 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3412 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 28968 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 7105 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 21406 | 0.010 |
Why?
|